Private Advisor Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Private Advisor Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40,100	Closed	-$8.44K	–	2389
2023 Q2	$8.44K	Hold	40,100	–	–	﹤0.01%	2008
2023 Q1	$6.42K	Hold	40,100	–	–	﹤0.01%	1952
2022 Q4	$22	Hold	40,100	–	–	﹤0.01%	1642
2022 Q3	$48K	Sell	40,100 -3,500	-8%	-$3.77K	﹤0.01%	1838
2022 Q2	$28K	Buy	43,600 +1,000	+2%	+$768	﹤0.01%	2055
2022 Q1	$49K	Buy	42,600 +9,100	+27%	+$10.9K	﹤0.01%	2042
2021 Q4	$75K	Sell	33,500 -17,000	-34%	-$42.7K	﹤0.01%	2055
2021 Q3	$173K	Buy	50,500 +38,000	+304%	+$117K	﹤0.01%	1896
2021 Q2	$37K	Hold	12,500	–	–	﹤0.01%	1947
2021 Q1	$40K	Buy	+12,500	New	+$41.7K	﹤0.01%	1855

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Private Advisor Group's INFI Position: Q3 2023 in Review

Private Advisor Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 40,100 shares — an estimated $8.44K sold.

Private Advisor Group first reported a position in INFI in Q1 2021 and held it in 10 quarters. The position peaked at $173K in Q3 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Private Advisor Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Private Advisor Group sold 40,100 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $8.44K.
Private Advisor Group first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 10 quarters.
Private Advisor Group's Infinity Pharmaceuticals, Inc. position peaked at $173K in Q3 2021.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Private Advisor Group's 13F filing for Q3 2023, filed 3 Nov 2023.